Townsquare Capital LLC Increases Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Townsquare Capital LLC increased its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 5.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,214 shares of the medical research company’s stock after buying an additional 666 shares during the period. Townsquare Capital LLC’s holdings in IQVIA were worth $2,894,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in IQV. Capital Performance Advisors LLP acquired a new position in shares of IQVIA in the third quarter worth about $27,000. Park Place Capital Corp purchased a new position in shares of IQVIA during the 3rd quarter valued at approximately $28,000. Versant Capital Management Inc increased its stake in shares of IQVIA by 733.3% in the second quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock worth $26,000 after buying an additional 110 shares during the last quarter. Opal Wealth Advisors LLC acquired a new stake in IQVIA in the second quarter valued at $27,000. Finally, Itau Unibanco Holding S.A. bought a new position in IQVIA during the 2nd quarter valued at $29,000. 89.62% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on IQV. JPMorgan Chase & Co. dropped their target price on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a research report on Tuesday, November 5th. StockNews.com cut IQVIA from a “buy” rating to a “hold” rating in a research note on Thursday. Morgan Stanley lowered their price target on IQVIA from $280.00 to $265.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft reduced their price objective on IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Finally, Evercore ISI lowered their target price on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, IQVIA currently has an average rating of “Moderate Buy” and a consensus target price of $256.50.

IQVIA Trading Down 0.3 %

NYSE:IQV opened at $200.84 on Friday. The stock has a market cap of $36.45 billion, a price-to-earnings ratio of 26.36, a PEG ratio of 2.07 and a beta of 1.51. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. IQVIA Holdings Inc. has a 1 year low of $187.62 and a 1 year high of $261.73. The business has a fifty day moving average of $218.67 and a 200-day moving average of $226.17.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.